Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.


N/A
18 Years
N/A
Open (Enrolling)
Both
Head and Neck Cancer

Thank you

Trial Information

Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.


Inclusion Criteria:



- All patients with N+ squamous cell carcinoma of the head and neck, planned for neck
dissection.

- Age >18 years.

Exclusion Criteria:

- Pregnancy.

- Women breast feeding

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

How accurate are the various FDG-PET segmentation tools?

Outcome Time Frame:

Measurements are performed in conjunction with the clinical pathologist directly postoperatively.

Safety Issue:

No

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

2008/060

NCT ID:

NCT00782691

Start Date:

July 2008

Completion Date:

Related Keywords:

  • Head and Neck Cancer
  • FDG-PET segmentation tools
  • Head-and-neck cancer
  • Histological validation
  • Carcinoma
  • Head and Neck Neoplasms
  • Neoplasm Metastasis
  • Carcinoma, Squamous Cell

Name

Location